{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "35-year-old man with pulmonary nodules found during routine health assessment 2 years ago, nodules enlarged progressively with follow-up. Smoked about 1 pack of cigarettes per day for 15 years and had no family history of hereditary disease or cancer.",
        "clinical_data": {
          "social_history": [
            {
              "category": "smoking",
              "status": "past",
              "description": "Smoked about 1 pack of cigarettes per day for 15 years"
            }
          ],
          "diagnoses": [
            {
              "code": "410605003",
              "label": "Pulmonary nodule (finding)",
              "status": "active",
              "onset_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "timestamp": "2023-02-15",
        "content": "CT scan revealed a 4.6 cm \u00d7 2.8 cm soft tissue mass in the left inferior lobe with obstructive changes. PET-CT scan indicated high 18-fluorodeoxyglucose (FDG) uptake in left inferior lobe mass.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Mass of soft tissue",
              "body_part": "Left inferior lobe",
              "modality": "CT",
              "finding": "4.6 cm \u00d7 2.8 cm soft tissue mass in the left inferior lobe with obstructive changes",
              "date": null
            },
            {
              "type": "Fluorodeoxyglucose F-18",
              "body_part": "Left inferior lobe mass",
              "modality": "PET",
              "finding": "high 18-fluorodeoxyglucose (FDG) uptake in left inferior lobe mass",
              "date": null
            }
          ]
        }
      }
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "Mass (4.94 cm \u00d7 3.47 cm; SUV, 13.8) in left hilar (stations 4L) and mediastinal lymph nodes (stations 7 and 8), suggesting malignant disease and lymph node metastasis with no signs of distant metastasis.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Mass",
              "body_part": "Left hilar and mediastinal lymph nodes",
              "modality": "PET",
              "finding": "Mass (4.94 cm \u00d7 3.47 cm; SUV, 13.8) in left hilar (stations 4L) and mediastinal lymph nodes (stations 7 and 8), suggesting malignant disease and lymph node metastasis with no signs of distant metastasis."
            }
          ],
          "diagnoses": [
            {
              "code": "C0242391",
              "label": "Malignant disease",
              "status": "suspected"
            },
            {
              "code": "C0024174",
              "label": "Lymph node metastasis",
              "status": "suspected"
            }
          ]
        }
      }
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "Endobronchial ultrasound-guided transbronchial lung biopsy (EBUS-TBLB) of the left lung mass showed adenocarcinoma.",
        "clinical_data": {
          "procedures": [
            {
              "name": "Endobronchial ultrasound-guided transbronchial lung biopsy",
              "approach": "endoscopic",
              "location": "left lung",
              "outcome": "adenocarcinoma"
            }
          ],
          "diagnoses": [
            {
              "code": "C0001673",
              "label": "Adenocarcinoma",
              "status": "active",
              "onset_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "Immunohistochemistry: positive staining for Napsin A, cytokeratin (CK), thyroid transcription factor-1 (TTF-1), and ALK. Next-generation sequencing: EML4-ALK fusion. Diagnosis: clinical stage IIIA [8th American Joint Committee on Cancer (AJCC): cT2bN2M0] pulmonary adenocarcinoma with left hilar and mediastinal lymph nodes metastasis.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0279839",
              "label": "Adenocarcinoma of lung",
              "status": "active"
            },
            {
              "code": "C4022924",
              "label": "stage IIIA",
              "status": "active"
            }
          ],
          "imaging": [
            {
              "type": "C0006115",
              "body_part": "C0024913",
              "modality": "other",
              "finding": "left hilar and mediastinal lymph nodes metastasis"
            }
          ]
        }
      }
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "Treatment with neoadjuvant lorlatinib (100 mg daily) administered from March 7, 2023, to June 28, 2023.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C1444739",
              "dosage": "100 mg",
              "frequency": "daily",
              "modality": "oral",
              "start_date": "2023-03-07",
              "end_date": "2023-06-28",
              "indication": null
            }
          ]
        }
      }
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Progression of pulmonary nodules led to further investigation.",
        "transition_event": {
          "trigger_type": "progression",
          "trigger_entities": [
            "C410605003"
          ],
          "change_type": "progression",
          "target_domain": "imaging"
        }
      }
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "Further imaging to assess the extent of the mass.",
        "transition_event": {
          "trigger_type": "imaging",
          "trigger_entities": [
            "C0022621"
          ],
          "change_type": "addition",
          "target_domain": "imaging",
          "timestamp": "2023-02-15"
        }
      }
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "Biopsy performed to determine the nature of the mass.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [
            "C0005841"
          ],
          "change_type": "addition",
          "target_domain": "procedure"
        }
      }
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "Further characterization of the adenocarcinoma with immunohistochemistry and next-generation sequencing.",
        "transition_event": {
          "trigger_type": "lab_change",
          "trigger_entities": [
            "C0001673"
          ],
          "change_type": "reinterpretation",
          "target_domain": "diagnosis"
        }
      }
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "Treatment initiated with neoadjuvant lorlatinib.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C1444739"
          ],
          "change_type": "addition",
          "target_domain": "medication",
          "timestamp": "2023-03-07"
        }
      }
    }
  ]
}